Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

246 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association between tissue characteristics assessed with optical coherence tomography and mid-term results after percutaneous coronary intervention for in-stent restenosis lesions: a comparison between balloon angioplasty, paclitaxel-coated balloon dilatation, and drug-eluting stent implantation.
Tada T, Kadota K, Hosogi S, Miyake K, Ohya M, Amano H, Izawa Y, Kanazawa T, Kubo S, Ichinohe T, Hyoudou Y, Hayakawa Y, Sabbah MM, Otsuru S, Hasegawa D, Habara S, Tanaka H, Fuku Y, Katoh H, Goto T, Mitsudo K. Tada T, et al. Among authors: ohya m. Eur Heart J Cardiovasc Imaging. 2015 Oct;16(10):1101-11. doi: 10.1093/ehjci/jev031. Epub 2015 Mar 9. Eur Heart J Cardiovasc Imaging. 2015. PMID: 25762559
Stent Fracture After Sirolimus-Eluting Stent Implantation: 8-Year Clinical Outcomes.
Ohya M, Kadota K, Tada T, Habara S, Shimada T, Amano H, Izawa Y, Hyodo Y, Miyake K, Otsuru S, Hasegawa D, Tanaka H, Maruo T, Katoh H, Fuku Y, Goto T, Mitsudo K. Ohya M, et al. Circ Cardiovasc Interv. 2015 Aug;8(8):e002664. doi: 10.1161/CIRCINTERVENTIONS.115.002664. Circ Cardiovasc Interv. 2015. PMID: 26227346
Impact of lesion calcification on angiographic outcomes after Absorb everolimus-eluting bioresorbable vascular scaffold implantation: an observation from the ABSORB Japan trial.
Ohya M, Kadota K, Sotomi Y, Kozuma K, Tanabe K, Uematsu M, Kawasaki T, Morino Y, Tobaru T, Nakao K, Tachibana K, Kishi K, Shibata Y, Ying S, Kusano H, Stone GW, Popma JJ, Onuma Y, Serruys PW, Kimura T. Ohya M, et al. EuroIntervention. 2017 Feb 20;12(14):1738-1746. doi: 10.4244/EIJ-D-16-00359. EuroIntervention. 2017. PMID: 27821375 Free article. Clinical Trial.
Long-Term Outcomes After Stent Implantation for Left Main Coronary Artery (from the Multicenter Assessing Optimal Percutaneous Coronary Intervention for Left Main Coronary Artery Stenting Registry).
Ohya M, Kadota K, Toyofuku M, Morimoto T, Higami H, Fuku Y, Yamaji K, Muranishi H, Yamaji Y, Nishida K, Furukawa D, Tada T, Ko E, Ando K, Sakamoto H, Tamura T, Kawai K, Kimura T; AOI LMCA Stenting Registry Investigators. Ohya M, et al. Am J Cardiol. 2017 Feb 1;119(3):355-364. doi: 10.1016/j.amjcard.2016.10.033. Epub 2016 Oct 31. Am J Cardiol. 2017. PMID: 27887688
Late Restenosis After Both First-Generation and Second-Generation Drug-Eluting Stent Implantations Occurs in Patients With Drug-Eluting Stent Restenosis.
Habara S, Kadota K, Kuwayama A, Shimada T, Ohya M, Miura K, Amano H, Kubo S, Hyodo Y, Otsuru S, Tada T, Tanaka H, Fuku Y, Goto T. Habara S, et al. Among authors: ohya m. Circ Cardiovasc Interv. 2016 Dec;9(12):e004449. doi: 10.1161/CIRCINTERVENTIONS.116.004449. Circ Cardiovasc Interv. 2016. PMID: 27932532
246 results